Nuvation Bio Inc (NUVB) Inventory Turnover Ratio, from third quarter 2026 to third quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Nuvation Bio Inc   (NYSE: NUVB)
 

Nuvation Bio Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

According to the latest Balance sheet Sep 30 2026, Nuvation Bio Inc has not recorded any inventories.
Visit Nuvation Bio Inc Balance sheet

Within Healthcare sector 335 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1458 in the second quarter 2026, to 1732.

NUVB Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Nuvation Bio Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NUVB Inventory Turnover Ratio (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Inventory Growth 168.6 % 3505.25 % 113071.43 % - -
Y / Y Cost of Sales Growth - - - 40 % 200 %
Inventory Turnover Ratio (TTM) - - - 3.17 7.65
NUVB's Total Ranking # 1732 # 1458 # 951 # 0 #
Average inventory processing period - - - 115 48
Seq. Inventory Growth -22.93 % 25.61 % 38.85 % 99.84 % 934.42 %
Seq. Cost of Sales Growth - - - 133.33 % 50 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 102
Healthcare Sector # 336
Overall Market # 1732

Inventory Turnover Ratio Statistics
High Average Low
3.17 1.78 0.76
(Dec 31 2025)   (Jun 30 2026)



NUVB Company Profile >> Back to NUVB Efficiency Comparisons >> Compare NUVB Inventory Turnover Ratio to its Competitors

Financial Statements
Nuvation Bio Inc 's Inventories $ 15 Millions Visit NUVB's Balance sheet
Nuvation Bio Inc 's Cost of Revenues TTM $ 7 Millions Visit NUVB's Income Statement
What are NUVB's Sales? Visit NUVB's Sales by Segment

Other Inventory Turnover Ratios
Nuvation Bio Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
NUVB's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for NUVB's Competitors
Inventory Turnover Ratio for NUVB's Suppliers
Inventory Turnover Ratio for NUVB's Customers

You may also want to know
NUVB's Sales Growth Rates NUVB's Pe Price to earnings ratio NUVB's Receivables Turnover Ratio NUVB's Stock Quote
NUVB's Net Income Growth Rates NUVB's Ps Price to Sales ratio NUVB's Sales per Employee NUVB's Asset Turnover Ratio
NUVB's Net Margin NUVB's Pb Price to Book ratio NUVB's Financial Strength Ratios NUVB's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2026 Inventories at quarter ending Sep 30 2026
Si bone inc   1.25 $ 46.999  Millions$ 38  Millions
Bridgebio Pharma Inc   1.24 $ 53.542  Millions$ 43  Millions
Biogen Inc   1.23 $ 2,681.800  Millions$ 2,181  Millions
Lensar Inc   1.22 $ 28.813  Millions$ 24  Millions
Kiniksa Pharmaceuticals International Plc  1.21 $ 93.072  Millions$ 77  Millions
Mannkind Corporation  1.16 $ 51.332  Millions$ 44  Millions
Rhythm Pharmaceuticals Inc   1.14 $ 33.056  Millions$ 29  Millions
Penumbra Inc  1.13 $ 499.548  Millions$ 443  Millions
Teleflex Incorporated  1.12 $ 427.166  Millions$ 380  Millions
Acadia Pharmaceuticals Inc   1.12 $ 114.422  Millions$ 102  Millions
Corcept Therapeutics Inc  1.11 $ 14.097  Millions$ 13  Millions
Alkermes Plc   1.10 $ 300.119  Millions$ 273  Millions
Neurocrine Biosciences Inc   1.07 $ 81.200  Millions$ 76  Millions
Emergent Biosolutions Inc   1.07 $ 334.800  Millions$ 314  Millions
Seer Inc   1.03 $ 7.698  Millions$ 7  Millions
Vertex Pharmaceuticals Inc  1.00 $ 1,874.100  Millions$ 1,866  Millions
Beone Medicines Ltd   0.99 $ 701.426  Millions$ 708  Millions
Amarin Corp Plcuk  0.92 $ 104.502  Millions$ 113  Millions
Eli Lilly And Company  0.89 $ 14,149.700  Millions$ 15,815  Millions
Cerus Corporation  0.87 $ 54.000  Millions$ 62  Millions
Maxcyte inc   0.86 $ 6.538  Millions$ 8  Millions
Co diagnostics Inc   0.82 $ 0.689  Millions$ 1  Millions
Rxsight Inc   0.82 $ 29.342  Millions$ 36  Millions
Profound Medical Corp   0.79 $ 6.177  Millions$ 8  Millions
Protalix Biotherapeutics inc   0.79 $ 24.384  Millions$ 31  Millions
Inspire Medical Systems inc   0.74 $ 122.959  Millions$ 165  Millions
Butterfly Network Inc   0.62 $ 37.120  Millions$ 60  Millions
Regeneron Pharmaceuticals Inc   0.60 $ 1,842.200  Millions$ 3,071  Millions
Lenz Therapeutics Inc   0.58 $ 2.228  Millions$ 4  Millions
Lexicon Pharmaceuticals Inc   0.58 $ 0.427  Millions$ 1  Millions

Date modified: 2026-11-06T13:04:17+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.